MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
DALLAS, July 23 /PRNewswire-FirstCall/ -- AC C E S S PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) , announced today that its European partner, SpePharm , is collecting data from a post approval study of MuGard in head
and neck cancer patients undergoing...
Oncolytics Biotech(R) Inc. Completes Patient Enrolment in U.K. Combination REOLYSIN(R) and Paclitaxel/Carboplatin Head and Neck Cancer Trial
CALGARY, July 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) announced today that patient enrolment has been completed in the Phase II component of a Phase I/II U.K. trial of REOLYSIN combined with paclitaxel/carboplatin for patients with advanced cancers. The princ...
BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
INDIANAPOLIS, June 29 /PRNewswire/ -- BioStorage Technologies, Inc. (BST), a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, announces the appointment of Jeff Goddard to global head
Goddard joins BST with nearly 15 year...
NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD & NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS
- Results from a randomized Phase IIb trial reported at 2009 ASCO Annual
MISSISSAUGA, ON, June 1 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI , TSX:YM, AIM:YMBA), a life sciences product development company that identifies and advances a diverse portfolio ...
Professor Hanna Nohynek Joins Encorium as Head Consultant of its Clinical Vaccine Research Team
WAYNE, Pa., May 7 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (Nasdaq: ENCO ), a full-service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials and patient registries to many of the world's leading pharmaceu...
Nfocus Neuromedical Appoints Robert O'Holla to Head Regulatory
Accomplished regulatory executive enhances Nfocus device development team.
PALO ALTO, Calif., April 30 /PRNewswire/ -- Endovascular device start-up Nfocus Neuromedical Inc. announced today the appointment of accomplished regulatory executive Robert O'Holla to its leadership team in the role...
Vantia Therapeutics Appoints Rachel Morten as Head of Regulatory Affairs
SOUTHAMPTON, England, April 21 /PRNewswire/ -- Vantia Therapeutics, a
company developing novel small molecule drugs targeting large underserved
medical markets, today announces the appointment of Rachel Morten as Head
Rachel has more than 24 years experience in gl...
Oncolytics Biotech(R) Inc. Collaborators Present Positive Head and Neck Results in Phase I/II Combination REOLYSIN(R) and Paclitaxel/Carboplatin Trial
CALGARY, March 20 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY ) announced that interim clinical results from its Phase I/II U.K. trial of REOLYSIN(R) combined with paclitaxel/carboplatin for patients with advanced cancers were presented at the Fifth International Mee...
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
BETHESDA, Md., Feb. 23 /PRNewswire/ -- Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that Dr. Kapil Dhingra has joined its Board of Directors, effective as ...
NeuroFocus Names John Polich, World-Renowned Scientist in Brain Function and Cognition, to Head Global NeuroLab Operations
BERKELEY, Calif., Jan. 28 /PRNewswire/ -- NeuroFocus, the world leader in
the rapidly-growing field of neuromarketing, announced today that it has named
preeminent cognitive neuroscientist John Polich, Ph.D., as its Director of
Global NeuroLab Operations.
The company made this selection...
Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
New hires bring over 25 years of life sciences marketing experience to Cyntellect
SAN DIEGO, Jan. 15 /PRNewswire/ -- Cyntellect, a privately-held life sciences company leading the development and commercialization of live cell analysis and manipulation systems, announced today that it ...
Fuld & Company Announces Appointment of MIT Fellow to Head Pharmaceutical Team's Strategic Gaming and Consulting Services
CAMBRIDGE, Mass., Dec. 16 /PRNewswire/ -- Fuld & Company today announced that Wayne Rosenkrans, Ph.D., will join the Company as vice president consulting, specializing in strategic gaming for the pharmaceutical and healthcare industries.
"We are excited to have Dr. Rosenkrans join t...
Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
SAN DIEGO, Sept. 25 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics,
Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment
of obesity and other central nervous system-related disorders, today
announced that Dr. Dennis Kim has joined the Company as Senior Vice
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
SAN DIEGO, Sept. 23 /PRNewswire-FirstCall/ -- Halozyme Therapeutics,
Inc. (Nasdaq: HALO ), a biopharmaceutical company developing and
commercializing products targeting the extracellular matrix, today
announced that Douglas B. Muchmore, MD, has joined the company as Vice
Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck
Technology Targets Tumors with Precise Image-Guided IMRT to Spare Healthy Surrounding Tissue
PALO ALTO, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Doctors at cancer
treatment centers in the United States and the Netherlands are now treating
head and neck cancer using R...
Darius Naigamwalla Appointed Senior Vice President and Head of the Brand Management Practice at Campbell Alliance
RALEIGH, N.C., Aug. 7 /PRNewswire/ -- Campbell Alliance, the leading
management consulting firm specializing in the pharmaceutical and biotech
industry, today announced that Darius Naigamwalla has been appointed Senior
Vice President and head
of the firm's Brand Management Practice. Mr.
Pharmasmart International Taps Top Executive Ashton Maaraba to Head Global Sales and Marketing
PharmaSmart International Inc, a Rochester, NY company today announced it is bringing aboard Ashton S. Maaraba, a key Pharmacy, Pharmacy Services & HBC industry leader, to head
up global sales and marketing.
(PRWEB) July 22, 2008 -- PharmaSmart International Inc, a ...
Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
SUNNYVALE, Calif., July 9 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq:
CPHD) today announced the appointment of leading molecular epidemiologist
and expert on Healthcare Associated Infections, Fred Tenover, Ph.D., as
Senior Director of Scientific Affairs. Dr. Tenover will serve as a liaison
A New President at the Head of the Genethon Laboratory
Yves Champey Takes Over From Bernard Barataud
EVRY, France, July 7 /PRNewswire/ -- The board of directors at Genethon
nominated a new president to head
the laboratory created in 1990 by the AFM
(French Muscular Dystrophy Association). Thus Yves Champey succeeds Bernard
BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs
NEWARK, N.J., June 25 /PRNewswire/ -- BioNeutral announced today that
Steve Browand will direct the company's efforts to sell its advanced
chemical technology products to the military, Homeland Security and
governmental departments. Steve Browand said, "I have reviewed the test
Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety
PHILADELPHIA, May 28 /PRNewswire/ -- Premier Research Group plc (AIM:
PRG), the international pharmaceutical services group, announces the
appointment of Anthony Faragasso, MD as Executive Director and Global Head
of Medical Management and Safety. In this position, Dr. Faragasso will lead
Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
SAN CARLOS, Calif., May 22 /PRNewswire-FirstCall/ -- Nektar
Therapeutics (Nasdaq: NKTR ) announced today that Bharatt Chowrira, Ph.D.,
J.D. has joined the Company as Chief Operating Officer and Head
PEGylation Business Unit. His responsibilities include overseeing and
managing all aspe...
ChemAxon Announces New CEO and Head of R&D
BUDAPEST, Hungary, May 12 /PRNewswire/ -- ChemAxon, a software
solutions provider for cheminformatics, today announced the appointment of
Alex Drijver as CEO. The arrival signals the companies increased focus on
business development and market position. Ferenc Csizmadia, founder and
Wyeth Research Head Robert R. Ruffolo, Jr., Ph.D., Announces Retirement
- Mikael Dohlsten, M.D., Ph.D., To Succeed As President, Wyeth Research -
MADISON, N.J., April 30 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE )
today announced that Robert R. Ruffolo, Jr., Ph.D., 58, will retire as
President, Wyeth Research and Senior Vice President, Wyeth, later this
year. He ...
EXL Announces Appointment of Rembert de Villa as Head of Transformation Services
NEW YORK and NEW DELHI, India, April 14 /PRNewswire-FirstCall/ --
ExlService Holdings, Inc. (Nasdaq: EXLS ), a recognized provider of business
solutions, today announced that Rembert de Villa has joined as Head
Transformation Services. EXL's Transformation Services offerings focus on
Touch Bionics appoints Head of Clinical Advocacy
Experienced industry professional hired to promote clinical awareness, support and partnerships in the U.S.
BOSTON, MA and LIVINGSTON, Scotland, April 2 /PRNewswire/ - Touch
Bionics, developer of the i-LIMB Hand, the world's first commercially
available bionic hand with artic...
Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations
FRANKFURT, Germany, February 25 /PRNewswire/ -- t2cure, a clinical
stage biopharmaceutical company developing novel regenerative therapies
based on autologous progenitor cells, announced today that it has appointed
Dr. Petra Rueck Head
of Clinical Operations.
"We are pleased to have Petra jo...
ZyGEM Appoints Leading Biotechnology Expert to Head Clinical Advisory Board
--Dr. Mark Ahn Brings ZyGEM Extensive Expertise in Developing and Commercializing Novel Clinical Products--
SOLANA BEACH, Calif., Feb. 14 /PRNewswire/ -- ZyGEM Corp. Ltd., a
leading provider of unique and innovative enzymatic solutions for DNA
extraction and detection and othe...
Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
Addition of Timothy Forsey, PhD, Further Strengthens Kendle's Global Regulatory Affairs Organization
CINCINNATI, Aug. 10 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL ), a
leading, global full-service clinical research organization, today
announced that Timothy Forsey, P...
Premier Research Appoints Global Head of Human Resources
PHILADELPHIA, Sept. 18 /PRNewswire/ -- Premier Research Group plc (AIM:
PRG) announces the appointment of W. Scott Keenen as its Vice President,
Global Human Resources. Mr. Keenen will be responsible for setting the
strategic direction and implementing activities related to maximizing the
It takes nerves for flies to keep a level head
The nerve connections that keep a fly's gaze stable during complex aerial manoeuvres, enabling it to respond quickly to obstacles in its flight path, are revealed in new detail in research published today (22 July 2008).
Scientists from Imperial College London have described the connections be...
Microrobots dance on something smaller than a pin's head
DURHAM, N.C. -- Microscopic robots crafted to maneuver separately without any obvious guidance are now assembling into self-organized structures after years of continuing research led by a Duke University computer scientist.
"It's marvelous to be able to do assembly and control at this fine a r...
SearchCIO quotes Alliant head at Fusion2006
Madison, Wis. Tech publication SearchCIO picked up Alliant Energy CEO Bill Harvey's comments at Fusion2006 CEO-CIO Symposium last week. Harvey took a contrarian view, considering the audience, talking about Alliant's position as a late adopter and its "dogmatic" insistance that IT projects ali...
Johnson Controls appoints Roell to head EOC
Milwaukee, Wis. - Building efficiency and power solutions giant Johnson Controls, Inc. has announced a reshuffling of its executive positions reflecting the creation an Executive Operating Committee.
Steve Roell, vice-chairman and executive vice president, was named chairman of the EOC, a co...
Oskar Anderson to succeed Miszewski as head of state technology division
Madison, Wis. - Oskar Anderson, chief information officer for the Wisconsin Department of Revenue since 2001, has been named to succeed Matt Miszewski as administrator of the state Division of Enterprise Technology .
Anderson, who is on vacation this week, will join the Department of Admin...
Sciclone ALH 3000 Liquid Handler: Functional Characterization of the High Volume Head - Part 1: Plate-to-Plate Precision Testing
Geoffrey Grove, Susan Ryan and Ed Alderman
Applied Science and Technology Department, Caliper Life Sciences, Inc., Hopkinton, MA 01748
The High Volume Head
is one of four multi-channel liquid handling options available for the Sciclone Advanced...
Chinese pharma-biotech dragon rears its head
- I am on the eve of departing for Osaka, Japan, for the Bio Japan 2006 conference as part of a small Illinois mission. I have written a number of times over the years about both the Japanese pharma and biotech industries, but I haven't been back to Japan for a few years and I'm looking forwar...
GenVec Reports Second Quarter 2009 Financial Results
...been and is currently being evaluated for its potential use in the treatment of several other cancers, including esophageal cancer, rectal cancer, and head
and neck cancer. GenVec also uses its proprietary adenovector technology to develop vaccines for infectious diseases including HIV, malaria, foot-and-...
SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
...rior to joining SEQUENOM, Ms. Keller was vice president, global clinical development for Shire Pharmaceuticals. Prior to joining Shire, Ms. Keller was head
of development operations and clinical trial recruitment services for Pfizer Global Research and Development.
An integral part of the company's...
Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results
...cing recurrence of CDI, even in high risk patient populations," said Michael N. Chang, Ph.D., Optimer's President and Chief Executive Officer. "As we head
into the second half of this year, we look forward to presenting additional data from this study at ICAAC and IDSA and we are focused on completing ou...